Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy
The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy Investigator Initiated Trial
Status: Enrolling
Updated:  3/20/2018
Methodist Healthcare, University Hospital
mi
from
Memphis, TN
The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy
The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy Investigator Initiated Trial
Status: Enrolling
Updated: 3/20/2018
Methodist Healthcare, University Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
NUTRITION: Natural Tocotrienol Against Ischemic Stroke Event
Human Blood Outcomes Following Tocotrienol Supplementation - NUTRITION Phase I and Phase IIA
Status: Enrolling
Updated:  3/20/2018
Ohio State University Medical Center
mi
from
Columbus, OH
NUTRITION: Natural Tocotrienol Against Ischemic Stroke Event
Human Blood Outcomes Following Tocotrienol Supplementation - NUTRITION Phase I and Phase IIA
Status: Enrolling
Updated: 3/20/2018
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Nutrition Blood Outcomes Following Tocotrienol N2B
Human Blood Outcomes Following Tocotrienol Supplementation - Nutrition Phase IIB NUTRITION PHASE IIB
Status: Enrolling
Updated:  3/20/2018
Mount Carmel Health System
mi
from
Columbus, OH
Nutrition Blood Outcomes Following Tocotrienol N2B
Human Blood Outcomes Following Tocotrienol Supplementation - Nutrition Phase IIB NUTRITION PHASE IIB
Status: Enrolling
Updated: 3/20/2018
Mount Carmel Health System
mi
from
Columbus, OH
Click here to add this to my saved trials
Nutrition Blood Outcomes Following Tocotrienol N2B
Human Blood Outcomes Following Tocotrienol Supplementation - Nutrition Phase IIB NUTRITION PHASE IIB
Status: Enrolling
Updated:  3/20/2018
Ohio State University
mi
from
Columbus, OH
Nutrition Blood Outcomes Following Tocotrienol N2B
Human Blood Outcomes Following Tocotrienol Supplementation - Nutrition Phase IIB NUTRITION PHASE IIB
Status: Enrolling
Updated: 3/20/2018
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Switching Relapsing Multiple Sclerosis Patients Treated With Natalizumab at Risk for Progressive Multifocal Leukoencephalopathy to Teriflunomide: Is This Safe and Effective?
Status: Enrolling
Updated:  3/20/2018
Phoenix Neurological Associates
mi
from
Phoenix, AZ
Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Switching Relapsing Multiple Sclerosis Patients Treated With Natalizumab at Risk for Progressive Multifocal Leukoencephalopathy to Teriflunomide: Is This Safe and Effective?
Status: Enrolling
Updated: 3/20/2018
Phoenix Neurological Associates
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Switching Relapsing Multiple Sclerosis Patients Treated With Natalizumab at Risk for Progressive Multifocal Leukoencephalopathy to Teriflunomide: Is This Safe and Effective?
Status: Enrolling
Updated:  3/20/2018
Multiple Sclerosis Center of Northeastern New York
mi
from
Latham, NY
Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Switching Relapsing Multiple Sclerosis Patients Treated With Natalizumab at Risk for Progressive Multifocal Leukoencephalopathy to Teriflunomide: Is This Safe and Effective?
Status: Enrolling
Updated: 3/20/2018
Multiple Sclerosis Center of Northeastern New York
mi
from
Latham, NY
Click here to add this to my saved trials
Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Switching Relapsing Multiple Sclerosis Patients Treated With Natalizumab at Risk for Progressive Multifocal Leukoencephalopathy to Teriflunomide: Is This Safe and Effective?
Status: Enrolling
Updated:  3/20/2018
Providence Multiple Sclerosis Center
mi
from
Portland, OR
Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Switching Relapsing Multiple Sclerosis Patients Treated With Natalizumab at Risk for Progressive Multifocal Leukoencephalopathy to Teriflunomide: Is This Safe and Effective?
Status: Enrolling
Updated: 3/20/2018
Providence Multiple Sclerosis Center
mi
from
Portland, OR
Click here to add this to my saved trials
Michigan Stroke Transitions Trial
The Michigan Stroke Transitions Trial (MISTT): Improving Care Transitions for Acute Stroke Patients Through a Patient-centered Home Based Case Management Program
Status: Enrolling
Updated:  3/20/2018
University of Michigan
mi
from
Ann Arbor, MI
Michigan Stroke Transitions Trial
The Michigan Stroke Transitions Trial (MISTT): Improving Care Transitions for Acute Stroke Patients Through a Patient-centered Home Based Case Management Program
Status: Enrolling
Updated: 3/20/2018
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Michigan Stroke Transitions Trial
The Michigan Stroke Transitions Trial (MISTT): Improving Care Transitions for Acute Stroke Patients Through a Patient-centered Home Based Case Management Program
Status: Enrolling
Updated:  3/20/2018
Sparrow Health System
mi
from
Lansing, MI
Michigan Stroke Transitions Trial
The Michigan Stroke Transitions Trial (MISTT): Improving Care Transitions for Acute Stroke Patients Through a Patient-centered Home Based Case Management Program
Status: Enrolling
Updated: 3/20/2018
Sparrow Health System
mi
from
Lansing, MI
Click here to add this to my saved trials
Michigan Stroke Transitions Trial
The Michigan Stroke Transitions Trial (MISTT): Improving Care Transitions for Acute Stroke Patients Through a Patient-centered Home Based Case Management Program
Status: Enrolling
Updated:  3/20/2018
Saint Joseph Mercy Health System
mi
from
Ypsilanti, MI
Michigan Stroke Transitions Trial
The Michigan Stroke Transitions Trial (MISTT): Improving Care Transitions for Acute Stroke Patients Through a Patient-centered Home Based Case Management Program
Status: Enrolling
Updated: 3/20/2018
Saint Joseph Mercy Health System
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated:  3/20/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated: 3/20/2018
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated:  3/20/2018
Medical University of South Carolina
mi
from
Charleston, SC
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated: 3/20/2018
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated:  3/20/2018
Yale University School of Medicine
mi
from
New Haven, CT
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated: 3/20/2018
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated:  3/20/2018
St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated: 3/20/2018
St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated:  3/20/2018
Mount Sinai-West
mi
from
New York, NY
Feasibility Study on LITT for Medical Refractory Epilepsy
Feasibility Study on Laser Interstitial Thermal Therapy Ablation for the Treatment of Medical Refractory Epilepsy (FLARE)
Status: Enrolling
Updated: 3/20/2018
Mount Sinai-West
mi
from
New York, NY
Click here to add this to my saved trials
Ischemic Preconditioning as an Intervention to Improve Stroke Rehabilitation - Froedtert
Ischemic Preconditioning as an Intervention to Improve Stroke Rehabilitation
Status: Enrolling
Updated:  3/20/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Ischemic Preconditioning as an Intervention to Improve Stroke Rehabilitation - Froedtert
Ischemic Preconditioning as an Intervention to Improve Stroke Rehabilitation
Status: Enrolling
Updated: 3/20/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Investigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive Patients
Investigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive Patients
Status: Enrolling
Updated:  3/20/2018
Multiple Sclerosis Center of Northeastern New York
mi
from
Latham, NY
Investigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive Patients
Investigating Indirect Mechanism of Neuroprotection of Tecfidera® (Dimethyl Fumarate) in RRMS and Progressive Patients
Status: Enrolling
Updated: 3/20/2018
Multiple Sclerosis Center of Northeastern New York
mi
from
Latham, NY
Click here to add this to my saved trials
Effect of Deep Brain Stimulation (DBS) on Sleep Architecture in Patients With Movement Disorders
Effect of DBS on Sleep Architecture in Patients With Movement Disorders.
Status: Enrolling
Updated:  3/22/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Effect of Deep Brain Stimulation (DBS) on Sleep Architecture in Patients With Movement Disorders
Effect of DBS on Sleep Architecture in Patients With Movement Disorders.
Status: Enrolling
Updated: 3/22/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Treatment of Rett Syndrome With Recombinant Human IGF-1
Pharmacological Treatment of Rett Syndrome by Stimulation of Synaptic Maturation With Recombinant Human IGF-1(Mecasermin [rDNA] Injection)
Status: Enrolling
Updated:  3/23/2018
Boston Children's Hospital
mi
from
Boston, MA
Treatment of Rett Syndrome With Recombinant Human IGF-1
Pharmacological Treatment of Rett Syndrome by Stimulation of Synaptic Maturation With Recombinant Human IGF-1(Mecasermin [rDNA] Injection)
Status: Enrolling
Updated: 3/23/2018
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated:  3/23/2018
The Kirkland Clinic of UAB Hospital
mi
from
Birmingham, AL
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated: 3/23/2018
The Kirkland Clinic of UAB Hospital
mi
from
Birmingham, AL
Click here to add this to my saved trials
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated:  3/23/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated: 3/23/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated:  3/23/2018
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated: 3/23/2018
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated:  3/23/2018
University of California, Irvine
mi
from
Irvine, CA
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated: 3/23/2018
University of California, Irvine
mi
from
Irvine, CA
Click here to add this to my saved trials
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated:  3/23/2018
Ronald Reagan UCLA Medical Center - Drug Information Center
mi
from
Los Angeles, CA
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated: 3/23/2018
Ronald Reagan UCLA Medical Center - Drug Information Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated:  3/23/2018
UCLA Neurology Clinic
mi
from
Los Angeles, CA
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated: 3/23/2018
UCLA Neurology Clinic
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated:  3/23/2018
Rocky Mountain Movement Disorders Center
mi
from
Englewood, CO
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated: 3/23/2018
Rocky Mountain Movement Disorders Center
mi
from
Englewood, CO
Click here to add this to my saved trials
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated:  3/23/2018
Indiana University Health Neuroscience Center
mi
from
Indianapolis, IN
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated: 3/23/2018
Indiana University Health Neuroscience Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated:  3/23/2018
Albany Medical College
mi
from
Albany, NY
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated: 3/23/2018
Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated:  3/23/2018
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated: 3/23/2018
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated:  3/23/2018
Wexner Medical Center at the Ohio State University
mi
from
Columbus, OH
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated: 3/23/2018
Wexner Medical Center at the Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated:  3/23/2018
Baylor College of Medicine
mi
from
Houston, TX
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated: 3/23/2018
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated:  3/23/2018
University of Florida Center for Movement Disorders and Neurorestoration
mi
from
Gainesville, FL
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated: 3/23/2018
University of Florida Center for Movement Disorders and Neurorestoration
mi
from
Gainesville, FL
Click here to add this to my saved trials
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated:  3/23/2018
The Centre For Huntington Disease, The University of British Columbia
mi
from
Vancouver,
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated: 3/23/2018
The Centre For Huntington Disease, The University of British Columbia
mi
from
Vancouver,
Click here to add this to my saved trials
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated:  3/23/2018
UCLA Radiology
mi
from
Los Angeles, CA
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated: 3/23/2018
UCLA Radiology
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated:  3/23/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated: 3/23/2018
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated:  3/23/2018
Ohio State University
mi
from
Columbus, OH
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated: 3/23/2018
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated:  3/23/2018
The Wright Center of Innovation- The Ohio State University
mi
from
Columbus, OH
Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
An Open Label Extension Study To Investigate The Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Previously Completed Study A8241021
Status: Enrolling
Updated: 3/23/2018
The Wright Center of Innovation- The Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
T-Regulatory Cells in Amyotrophic Lateral Sclerosis
Expansion and Infusion of T-Regulatory Cells in Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  3/23/2018
Methodist Neurological Institute
mi
from
Houston, TX
T-Regulatory Cells in Amyotrophic Lateral Sclerosis
Expansion and Infusion of T-Regulatory Cells in Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 3/23/2018
Methodist Neurological Institute
mi
from
Houston, TX
Click here to add this to my saved trials
A Study in Older Participants Who Have Fallen and Have Muscle Weakness
A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Who Have Fallen Recently and Have Muscle Weakness
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Aurora, CO
A Study in Older Participants Who Have Fallen and Have Muscle Weakness
A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Who Have Fallen Recently and Have Muscle Weakness
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study in Older Participants Who Have Fallen and Have Muscle Weakness
A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Who Have Fallen Recently and Have Muscle Weakness
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Gainesville, GA
A Study in Older Participants Who Have Fallen and Have Muscle Weakness
A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Who Have Fallen Recently and Have Muscle Weakness
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Gainesville, GA
Click here to add this to my saved trials
A Study in Older Participants Who Have Fallen and Have Muscle Weakness
A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Who Have Fallen Recently and Have Muscle Weakness
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Boston, MA
A Study in Older Participants Who Have Fallen and Have Muscle Weakness
A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Who Have Fallen Recently and Have Muscle Weakness
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study in Older Participants Who Have Fallen and Have Muscle Weakness
A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Who Have Fallen Recently and Have Muscle Weakness
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Saint Louis, MO
A Study in Older Participants Who Have Fallen and Have Muscle Weakness
A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Who Have Fallen Recently and Have Muscle Weakness
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study in Older Participants Who Have Fallen and Have Muscle Weakness
A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Who Have Fallen Recently and Have Muscle Weakness
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Winston-Salem, NC
A Study in Older Participants Who Have Fallen and Have Muscle Weakness
A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Who Have Fallen Recently and Have Muscle Weakness
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study in Older Participants Who Have Fallen and Have Muscle Weakness
A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Who Have Fallen Recently and Have Muscle Weakness
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Galveston, TX
A Study in Older Participants Who Have Fallen and Have Muscle Weakness
A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Who Have Fallen Recently and Have Muscle Weakness
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Galveston, TX
Click here to add this to my saved trials
A Study in Older Participants Who Have Fallen and Have Muscle Weakness
A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Who Have Fallen Recently and Have Muscle Weakness
Status: Enrolling
Updated:  3/24/2018
Clinical Research Facility
mi
from
Madison, WI
A Study in Older Participants Who Have Fallen and Have Muscle Weakness
A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Who Have Fallen Recently and Have Muscle Weakness
Status: Enrolling
Updated: 3/24/2018
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
A Study in Older Participants Who Have Fallen and Have Muscle Weakness
A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Who Have Fallen Recently and Have Muscle Weakness
Status: Enrolling
Updated:  3/24/2018
mi
from
Buenos Aires,
A Study in Older Participants Who Have Fallen and Have Muscle Weakness
A Phase 2 Randomized Study to Investigate the Efficacy and Safety of LY2495655 Versus Placebo in Older Patients Who Have Fallen Recently and Have Muscle Weakness
Status: Enrolling
Updated: 3/24/2018
mi
from
Buenos Aires,
Click here to add this to my saved trials
EEG Characteristics in Youth POTS and/or Syncope
Electroencephalographic (EEG) Characteristics of Postural Tachycardia Syndrome (POTS) and Syncope (Without POTS) During Head-upright Tilt Table Testing
Status: Enrolling
Updated:  3/25/2018
Nationwide Children's Hopsital
mi
from
Columbus, OH
EEG Characteristics in Youth POTS and/or Syncope
Electroencephalographic (EEG) Characteristics of Postural Tachycardia Syndrome (POTS) and Syncope (Without POTS) During Head-upright Tilt Table Testing
Status: Enrolling
Updated: 3/25/2018
Nationwide Children's Hopsital
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Indianapolis, IN
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Seattle, WA
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated:  3/26/2018
Clinical Research Facility
mi
from
Spring Valley, CA
A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder
Long-Term, Open-Label, Safety Study of LY2216684 in Pediatric Patients With Attention Deficit/Hyperactivity Disorder
Status: Enrolling
Updated: 3/26/2018
Clinical Research Facility
mi
from
Spring Valley, CA
Click here to add this to my saved trials